Is this you? Create Your Porfile
Avatar

Kouji Oohashi

SANTEN PHARMACEUTICAL CO., LTD.

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Kouji Oohashi is active.

Explore More

Publication

Featured researches published by Kouji Oohashi.

Archive | 2010

Prophylactic or therapeutic agent for retinal disease and method for prophylaxis or therapy of retinal disease using jnk (c-jun amino-terminal kinase)-inhibitory peptide, and use of the peptide

Shin-Ichiro Hirai; Tokiyoshi Matsushita; Yukie Fujita; Hiroaki Kurashima; Kouji Oohashi

Archive | 2010

Prophylactic or therapeutic agent for retinal diseases and method for preventing or treating retinal diseases, each comprising jnk (c-jun n-terminal kinase)-inhibiting peptide, and use of the peptide

Shin-Ichiro Hirai; Tokiyoshi Matsushita; Yukie Fujita; Hiroaki Kurashima; Kouji Oohashi

Archive | 2006

Protective Agent for Neuronal Cell Comprising Amidino Derivative as Active Ingredient

Kouji Oohashi; Reina Doi; Masaaki Kageyama

Archive | 2006

Angiogenesis Inhibitor Containing Amine Derivative as Active Ingredient

Kouji Oohashi; Reina Doi; Tatsuji Kurose; Masaaki Kageyama

Archive | 2011

イソキノリンスルホニル誘導体を有効成分として含有する網脈絡膜変性疾患の予防または治療剤、網脈絡膜変性疾患の予防または治療方法、イソキノリンスルホニル誘導体またはその医薬的に許容される塩、ならびにその使用

Kouji Oohashi; 康司 大橋; Shinichiro Hirai; 平井 慎一郎; Masaaki Kageyama; 景山 正明; Kenichi Endo; 健一 遠藤

Archive | 2011

Method of treating retinal vein occlusion

Kouji Oohashi; Reina Doi; Tatsuji Kurose; Masaaki Kageyama

Archive | 2011

Method of treating diabetic retinopathy

Kouji Oohashi; Reina Doi; Tatsuji Kurose; Masaaki Kageyama

Archive | 2011

Prophylactic or therapeutic agent for retinal/choroidal denaturation diseases comprising isoquinolinesulfonyl derivative as active ingredient, prophylactic or therapeutic method for retinal/choroidal denaturation diseases, and isoquinolinesulfonyl derivative or pharmaceutically acceptable salt thereof and use thereof

Kouji Oohashi; 康司 大橋; Shinichiro Hirai; 平井 慎一郎; Masaaki Kageyama; 景山 正明; Kenichi Endo; 健一 遠藤

Archive | 2010

ＪＮＫ（ｃ－Ｊｕｎアミノ末端キナーゼ）阻害ペプチドを用いた網膜疾患の予防または治療剤、網膜疾患の予防または治療方法、ならびに、その使用

Shinichiro Hirai; 平井 慎一郎; Tokiyoshi Matsushita; 登起義 松下; Yukie Fujita; 由紀恵 藤田; Hiroaki Kurashima; 宏明 倉島; Kouji Oohashi; 康司 大橋

Archive | 2006

Ein aminderivat als wirkstoff enthaltender angiogeneseinhibitor An amine derivative containing as active ingredient angiogenesis inhibitor

Kouji Oohashi; Reina Doi; Tatsuji Kurose; Masaaki Kageyama

Explore More

Collaboration

Dive into the Kouji Oohashi's collaboration.

Top Co-Authors
Avatar

Masaaki Kageyama

SANTEN PHARMACEUTICAL CO.

View shared research outputs
Top Co-Authors
Avatar

Reina Doi

SANTEN PHARMACEUTICAL CO.

View shared research outputs
Top Co-Authors
Avatar

Tatsuji Kurose

SANTEN PHARMACEUTICAL CO.

View shared research outputs
Top Co-Authors
Avatar

Hiroaki Kurashima

SANTEN PHARMACEUTICAL CO.

View shared research outputs
Top Co-Authors
Avatar

Tokiyoshi Matsushita

SANTEN PHARMACEUTICAL CO.

View shared research outputs
Top Co-Authors
Avatar

Yukie Fujita

SANTEN PHARMACEUTICAL CO.

View shared research outputs
Top Co-Authors
Avatar

Shinichiro Hirai

National Archives and Records Administration

View shared research outputs
Top Co-Authors
Avatar

Shin-Ichiro Hirai

SANTEN PHARMACEUTICAL CO.

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge